Master AI-Enabled CADD & Machine Learning for Drug Design in 4 weeks through hands-on, project-based online training with DSTC.
Computer-Aided Drug Design has become an indispensable part of modern pharmaceutical research. By simulating molecular interactions, predicting ADMET properties, and screening millions of compounds virtually, CADD significantly speeds up early-stage drug discovery. Every participant receives a verified e-Certificate and e-Marksheet from the Deep Science & Technology Consortium.
Computer-Aided Drug Design has become an indispensable part of modern pharmaceutical research. By simulating molecular interactions, predicting ADMET properties, and screening millions of compounds virtually, CADD significantly speeds up early-stage drug discovery.
1. Translate biotechnology theory into practical, reproducible analysis.
2. Assemble a documented case study that evidences your applied capability.
β’ Master's and senior undergraduate students specializing in biotechnology
β’ R&D engineers and working professionals applying biotechnology in industry
β’ Academics and educators building research or teaching capacity in biotechnology
β’ Tangible, reproducible biotechnology work to show supervisors or employers.
β’ A verified e-Certificate of competency and e-Marksheet from the Deep Science & Technology Consortium.
β’ Binding site detection with fpocket and the risk of screening a crystallographic artefact
β’ Protonation states, tautomers and missing loops as the usual source of bad docking
β’ Holo versus apo structures and why induced fit breaks rigid-receptor assumptions
β’ ZINC and ChEMBL as sources, and the difference between purchasable and virtual
β’ Lipinski, Veber and PAINS filters β what each removes and what each wrongly removes
β’ 3D conformer generation with RDKit and the conformer-count trade-off
β’ AutoDock Vina and Glide scoring functions and their weak correlation with affinity
β’ Redocking and cross-docking as the only honest validation of a docking protocol
β’ Enrichment metrics: ROC AUC and BEDROC against DUD-E style decoys
β’ Molecular descriptors and fingerprints (ECFP) versus learned graph representations
β’ Scaffold splits rather than random splits, or the model reports fantasy accuracy
β’ ADMET endpoints β hERG, CYP inhibition, solubility β and the applicability domain
β’ Hit triage: consensus scoring, visual inspection and chemical common sense
β’ MM-GBSA rescoring and short MD to test pose stability before committing
β’ Documenting a screen so the result can be reproduced by someone else
| Parameter | Requirement |
|---|---|
| Covered Tool / Platform | AutoDock Vina |
| Covered Tool / Platform | PyRx |
| Covered Tool / Platform | SchrΓΆdinger Suite |
| Covered Tool / Platform | GROMACS |
| Covered Tool / Platform | ChemDraw |
| Covered Tool / Platform | Discovery Studio |
| Covered Tool / Platform | ADMET Predictor |
Based on 0 scholar submissions
No verified reviews published yet. Be the first to share your academic experience.
Your rating will help prospective scholars. Ratings below 3 stars are routed privately to the faculty mentor for immediate response.